Tag:

centri

Health

Tumori Rari e Lenti del Cordomi: Difficili da Curare per Posizione

by Chief Editor
written by Chief Editor

Why Carbon‑Ion Therapy Is Redefining the Treatment of Sacral Chordoma

Chordoma of the sacrum is an ultra‑rare bone tumor that affects fewer than 70 new patients a year in Italy. Although it grows slowly, its location at the base of the spine puts vital nerves and the sphincter complex at risk. For decades, surgeons have faced a painful dilemma: remove the tumor and risk permanent loss of bladder, bowel or sexual function, or opt for conventional radiotherapy that often fails to control the disease.

Breakthrough Evidence: The SACRO Study

The internationally‑coordinated SACRO (S​acral Chordoma: a Randomized & Observational study) enrolled 170 patients between 2017 and 2024. 1 Sixty‑seven received carbon‑ion adrotherapy, while 61 underwent surgery. Three‑year overall survival was **90 %** for both groups and local disease control reached **70 %**. The decisive advantage? Quality‑of‑life scores were markedly higher after adrotherapy, because patients avoided the debilitating loss of bladder and sexual function that can follow extensive surgery.

How Carbon Ions Work – A Technological Leap

Carbon ions release their energy at a precise depth (the Bragg peak), sparing surrounding tissue. This “laser‑like” precision allows oncologists to hit the tumor with up to three times the biological effectiveness of X‑rays while keeping healthy structures intact.

  • Precision: dose is concentrated inside the tumor, reducing collateral damage.
  • Speed: treatment courses are typically 1–2 weeks instead of 6–8 weeks for conventional radiotherapy.
  • Re‑irradiation: patients who received prior X‑ray radiotherapy can still be treated with carbon ions.

Real‑World Impact – Stories From the Front Line

Marco*, a 62‑year‑old carpenter from Lombardy, avoided a 10‑hour sacral resection and now walks unaided, thanks to carbon‑ion therapy at the CNAO (National Center for Hadrontherapy) in Pavia. A recent audit of the CNAO registry shows that **over 200 sacral‑chordoma patients** have been treated with carbon ions, with a 5‑year local‑control rate exceeding 80 %.

Future Trends Shaping the Next Decade

1. Personalized Dose‑Painting With AI

Artificial‑intelligence algorithms are already being trained on thousands of imaging datasets to “paint” the optimal dose distribution for each patient. Early trials indicate a potential 10‑15 % boost in tumor control without increasing toxicity.

2. Hybrid Photon‑Carbon Facilities

Europe is investing in combined photon‑and‑ion centers—e.g., the upcoming “Hybrid Radiotherapy Hub” in Milan—so patients can switch seamlessly between modalities, maximizing the therapeutic window.

3. Tele‑Oncology Follow‑Up

Remote monitoring platforms equipped with wearable sensors are being piloted to track urinary and bowel function after treatment, enabling physicians to intervene before disability becomes permanent.

4. Expanded Indications

Beyond sacral chordoma, trials are testing carbon ions for skull‑base chordomas, pediatric sarcomas, and even radio‑resistant lung metastases. The success of the SACRO trial fuels confidence that “non‑invasive” may soon become the default pathway for many rare bone cancers.

Did you know? The CNAO is one of only eight centers worldwide that can deliver both proton and carbon‑ion beams – a capability that places Italy at the forefront of particle‑therapy research.

Key Takeaways for Patients and Clinicians

  • Early detection saves function. Early MRI of unexplained sacral pain can catch chordoma before it threatens nerves.
  • Ask about carbon‑ion therapy. If you’re a candidate, the CNAO offers a fully reimbursed pathway through the SSN.
  • Multidisciplinary care is essential. Surgeons, radiation oncologists, and physiotherapists must coordinate to preserve quality of life.

FAQ

Is carbon‑ion therapy more expensive than surgery?
In Italy the national health service fully reimburses the procedure, making it cost‑neutral for patients compared with an extended hospital stay after surgery.
Can chordoma spread after treatment?
Yes, about 10‑15 % of patients develop metastases (lungs, liver, bone) within five years, underscoring the need for lifelong surveillance.
Is the treatment painful?
Patients report mild skin irritation at most; the beam stops at the tumor, sparing surrounding nerves.
How long does a carbon‑ion session last?
Each fraction lasts 5‑10 minutes; a full course is usually 12‑16 fractions.
Can children receive carbon‑ion therapy?
Yes, the CNAO treats adolescents and young adults, adjusting dose to limit growth‑plate damage.

Pro Tip for Readers

If you or a loved one experience persistent sacral pain, schedule an MRI and specifically ask the radiologist to “rule out chordoma.” Early imaging plus a multidisciplinary review can shift treatment from “high‑risk surgery” to “precision radiation.”

What’s Next?

Stay updated on the latest trials by following the Oncology Updates hub, and consider subscribing to our monthly newsletter for exclusive interviews with the scientists behind the SACRO study.

Join the conversation: Have you or someone you know faced a sacral chordoma? Share your story in the comments or contact us for personalized guidance.

0 comments
0 FacebookTwitterPinterestEmail
World

Israele-Hamas: Gaza in Diretta, Putin-Netanyahu, Trump e la Crisi Umanitaria

by Chief Editor
written by Chief Editor

The Two-State Solution: Navigating a Complex Future

<p>The global landscape surrounding the Israeli-Palestinian conflict is constantly evolving. Recent diplomatic efforts, particularly the UN-led conference co-chaired by France and Saudi Arabia, underscore the persistent push for a two-state solution. But what does the future hold, and what are the key trends we should be watching? As an expert in international relations, I've been following this closely, and I'm here to break it down.</p>

<h2 class="fxr-left-center is-mr-b-10 title-art is-small--bre-c-h is-line-h-118 liveblog__post__title">The Shifting Sands of International Recognition</h2>

<p>One of the most significant trends is the growing global momentum towards recognizing a Palestinian state. France's consideration of formal recognition, as well as the discussions at the UN, are testaments to this. Currently, 142 UN member states recognize Palestine. However, such steps are often met with resistance, particularly from the United States and Israel, which view them as premature or counterproductive. </p>

<p>&#x20;
   **Did you know?** The Palestinian Authority, established in 1994, has limited control over the West Bank and Gaza Strip. The Oslo Accords, signed in the 1990s, aimed to establish a framework for a two-state solution, but the process stalled.
</p>

<p>
  Recent data from the Pew Research Center highlights a divergence in public opinion on this issue. Support for a two-state solution varies significantly depending on the country and the political affiliation of the respondents. For instance, according to a 2023 poll, there were some differing views on the issue among countries.
</p>

<h3 class="fxr-left-center is-mr-b-10 title-art is-small--bre-c-h is-line-h-118 liveblog__post__title">The US Role: A Critical Variable</h3>

<p>The stance of the United States remains crucial. Its opposition to recognizing Palestine, as expressed during the recent UN conference, has a considerable impact on any progress. The US holds significant influence over the peace process and has historically been a key mediator. However, this role is being questioned as other powers, like the European Union and China, become more actively involved.</p>

<p>
  The US has voiced concerns over the current path of the two-state solution. For a balanced perspective, consider this <a href="https://www.state.gov/" target="_blank" rel="noopener">State Department</a> overview of the situation.
</p>

<h3 class="fxr-left-center is-mr-b-10 title-art is-small--bre-c-h is-line-h-118 liveblog__post__title">Beyond Recognition: Addressing the Core Issues</h3>

<p>The mere act of recognizing a Palestinian state is insufficient. A comprehensive approach must address the fundamental issues fueling the conflict. These include: </p>

<ul>
    <li><strong>Border Disputes:</strong> Defining the borders of a future Palestinian state remains a significant hurdle.</li>
    <li><strong>Security Concerns:</strong> Ensuring the security of both Israelis and Palestinians is paramount, including addressing the role of groups like Hamas.</li>
    <li><strong>Settlements:</strong> The expansion of Israeli settlements in the West Bank is widely considered illegal under international law and undermines the viability of a two-state solution.</li>
    <li><strong>Refugee Issue:</strong> The status of Palestinian refugees and their right of return are sensitive points of contention.</li>
</ul>

<p>
    <a href="https://www.un.org/unispal/history/" target="_blank" rel="noopener">The UN's archive</a> provides a comprehensive overview of the historical complexities of the Israeli-Palestinian conflict and the role of the UN.
</p>

<h3 class="fxr-left-center is-mr-b-10 title-art is-small--bre-c-h is-line-h-118 liveblog__post__title">The Role of Other Nations and Actors</h3>

<p>The involvement of regional and international actors is vital. France, Saudi Arabia, and other European nations are increasingly vocal in supporting the two-state solution. The Arab League also has a vital role to play, particularly in the normalization of relations with Israel and in supporting a Palestinian state.</p>

<p>
    <strong>Pro Tip:</strong> Monitor developments from key stakeholders like the EU, Russia, and China. Their positions and actions are increasingly influencing the trajectory of the peace process.
</p>

<h2 class="fxr-left-center is-mr-b-10 title-art is-small--bre-c-h is-line-h-118 liveblog__post__title">Challenges and Opportunities</h2>

<p>The path to a two-state solution is fraught with challenges, including political instability, extremist ideologies, and mistrust between the parties. However, it also presents opportunities. Diplomatic efforts, economic cooperation, and civil society initiatives can help build bridges and foster a more conducive environment for negotiations. The recent letter from retired Italian ambassadors, calling for formal recognition of Palestine, illustrates the pressure on governments to engage more actively.</p>

<h2 class="fxr-left-center is-mr-b-10 title-art is-small--bre-c-h is-line-h-118 liveblog__post__title">FAQ: Your Questions Answered</h2>

<p>Here are answers to frequently asked questions about the two-state solution:</p>

<p><strong>What is the two-state solution?</strong> It refers to a framework to resolve the Israeli-Palestinian conflict by establishing two states: Israel and Palestine, living side by side.</p>

<p><strong>Why is it so difficult to achieve?</strong> Key obstacles include border disputes, security concerns, the status of settlements, and the refugee issue.</p>

<p><strong>What are the key players involved?</strong> The main players are Israel, Palestine, the United States, the European Union, and various regional actors.</p>

<p><strong>Is it still a viable solution?</strong> Despite the challenges, many international actors still see the two-state solution as the most realistic path to a lasting peace.</p>

<h2 class="fxr-left-center is-mr-b-10 title-art is-small--bre-c-h is-line-h-118 liveblog__post__title">What's Next?</h2>

<p>The future of the two-state solution is uncertain, but several factors will shape its trajectory: the positions of major powers, the progress of negotiations, the evolution of public opinion, and the actions of both Israeli and Palestinian leaders. The coming months and years will be crucial.</p>

<p>
    What are your thoughts on the two-state solution? Share your perspective in the comments below and join the conversation!
</p>
0 comments
0 FacebookTwitterPinterestEmail
News

Referendum 2025: Results & Analysis – Low Turnout, Yes Vote Wins

by Chief Editor
written by Chief Editor
di
Renato Benedetto

The center-left does not pass the goal it had set for itself, and the data on citizenship stops at 9 million voters. More voters in ZTLs and in the “strong” areas of the Democratic Party, fewer in those of the 5 Stars.

Despite all the formulas and distinctions that animated the pre-vote debate — “I take two yeses and three noes”, “I only take two ballots, thank you…” — in the end, turnout was practically the same for all questions. As well as being far from the quorum: at 30.6% (Italy data, it is lower with the vote of Italians abroad, at 29.9). And, with the significant exception of the citizenship ballot, the results are also homogeneous, with the yes over 87%.

14.1 million voters went to the polls. Not enough to reach the quorum target. But it was another the bar set by the leaders of the center-left, reiterated in unison in yesterday’s declarations: exceeding the 12.3 million votes that in 2022, in the political elections, sent Giorgia Meloni to Palazzo Chigi (the data concerns the national territory and with this, therefore, the comparison is made here: it would rise to 12.6 with abroad). Comfortable bar, certainly, moreover, it was the promoters themselves who set it. But in the end, at least that one, was it overcome?

The Threshold Touched Upon

“The final data risks not even giving satisfaction to this threshold,” notes Lorenzo Pregliasco, director of YouTrend. Take the questions on work, where the Democratic Party, M5S and Avs were united for yes. Here they stopped at 12.250 million, considering the question that collected the most, on layoffs (Italy data), considering also the vote of Italians abroad we are just above 13 million. That is, they have touched on those famous 12.3, there was no clear overtaking. Only, in fact, considering the foreign polling stations, it exceeds, slightly, the 12.6 million of Meloni in 2022. “And on citizenship we are very far away“. The number of those who responded affirmatively to the proposal to halve the time for the request — supported by the Democratic Party, Avs, Action, Iv and +Europa — stops around 9 million. Evidentemente something didn’t work: “On the one hand there was a politicization of the questions, beyond the merits, and this distanced a part that is not militant. Pushing on the identity pedal, on the other hand, it was not enough to mobilize the opposition electorate in force,” comments Pregliasco.

DEEPEN WITH THE PODCAST
https://widget.spreaker.com/player?episode_id=66477520&theme=light&playlist=false" width="100%" height="200px" title="Referendum senza quorum. Scontri a Los Angeles. Israele ferma Greta Thunberg" frameborder="0

PD vs 5 Stars

Tuscany and Emilia-Romagna, strongholds of the Democratic Party, are the two regions where turnout is highest (39.1 and 38.1 respectively). In the South, in historical basins of the 5 Stars, percentages are recorded below the national average (23.1 in Sicily, 27.7 in Sardinia, a little better in Campania, 29.9). It is one of the first data discussed in the post-vote debate: a sign that should worry the 5 Star Movement? “A lower participation was expected in the South, it is a trend already recorded and in addition Article 18 and citizenship speak less to that electorate,” Pregliasco anticipates. But from the analysis of YouTrend a data emerges: “In the strongholds of the Democratic Party and Avs — that is, in the municipalities where these parties in 2022 and in the last European elections have cashed in better results than their national average — turnout was above 36%. In the strongholds of the 5 Stars below 28%”.

ZTLs and Peripheries

There is another piece of data, the distribution of votes in cities. In the historic centers of the big cities, the yes to citizenship were higher: 80% in the Milan 1 district (against 74% of the city average and above the national result) and in Turin 1 exceeds 81%, a result 5 points higher than layoffs. Here they have adhered more to citizenship than to work: from San Salvario to Mirafiori, in the popular areas, instead, the most voted were the questions on contracts. “Situation, that of ZTLs, which, as often happens, is not representative of the trends of the country”.

The Big Cities

Driving turnout are above all the big cities. For Salvatore Vassallo, professor of Political Science and director of the Istituto Cattaneo, one of the most evident data “is the difference between large and small centers“: “In the cities over 350 thousand inhabitants, on average, 7 percentage points of turnout were recorded more than the average of all the municipalities. The difference rises to 10 points if the comparison is made with the centers under 15 thousand inhabitants. This gap had never been recorded,” comments the political scientist. And not only “because in the large centers the voters of the broad field voted above all, and among these above all the voters of the Democratic Party”, think of Florence at 46.9 and Bologna at 47.7 (but then there are also Turin, 41.4%, Genoa, 40.4, Milan, 36.8, and Rome, 36.2). “Perhaps — he continues — there is something else, the citizens closest to the “structured networks” of the trade union, of the parties, have been mobilized”. On turnout, however, Vassallo does not speak of a collapse: “If we compare it with the referendums after 1999 — a key year that certified that a quota of strategic abstentionism is enough to block a consultation — we are substantially in line”.

Center-Right at the Polls

Be careful, however, to read these data with an excessively “parliamentary” tone, where the yeses are the opposition and the abstainers the majority. “In reality, it’s all more nuanced than that,” explains Antonio Noto, who directs Noto Sondaggi. The surveys on the vote have shown “that a fifth of the center-right electorate went to vote, while a third of the center-left electorate did not go to the polls. Even a part of the Democratic Party electorate did not go”.

The North versus South difference is marked. “Yes, the North voted more, but beyond Veneto, we find among the regions where turnout is highest Piedmont and Liguria, governed by the center-right”. According to Noto, an “down effect” for the late abstainers may have influenced the final result: “The data of Monday, of how many voted from 7 to 15, is lower in comparison with the data of the previous Mondays. Probably the result of Sunday evening has discouraged many from going to the polls“.

It should be noted that for the first time, turnout was higher among women than among men (with the only exception of Taranto, noted YouTrend). Only a year ago in 91 provinces the men had participated more.

Go to all the news from Rome

Subscribe to the Corriere Roma newsletter

June 10, 2025 ( modified on June 10, 2025 | 08:17)

0 comments
0 FacebookTwitterPinterestEmail
Health

3000 Nuove Diagnosi in Campania: Centri Specializzati

by Chief Editor
written by Chief Editor

Prostate Cancer Treatment: A Glimpse into the Future

The fight against prostate cancer is constantly evolving, with breakthroughs offering new hope for patients. Recent advancements, like the introduction of radioligand therapy in regions like Campania, Italy, highlight the ongoing efforts to provide more effective and personalized treatments. Let’s explore the future trends shaping the landscape of prostate cancer care.

Radioligand Therapy: Precision in Oncology

Radioligand therapy, as highlighted in the Campania initiative, represents a significant shift toward precision medicine. This targeted approach uses radioactive drugs (radioligands) that bind to specific proteins on cancer cells. This allows clinicians to deliver radiation directly to the tumor, minimizing damage to healthy tissues. This targeted approach improves outcomes and reduces side effects compared to conventional treatments like chemotherapy. The Campania initiative demonstrates a proactive approach in making this innovative treatment accessible.

Did you know? Radioligand therapy can be particularly effective for metastatic castration-resistant prostate cancer (mCRPC) where the cancer has spread and no longer responds to hormone therapy.

Beyond Radioligands: Emerging Treatment Modalities

While radioligand therapy holds immense promise, the future of prostate cancer treatment is multifaceted. Several other avenues are being explored, including:

  • Immunotherapy: Harnessing the body’s immune system to fight cancer. This approach shows potential, especially when combined with other treatments.
  • Next-Generation Hormonal Therapies: Research continues on developing more effective and less toxic hormonal therapies.
  • Combination Therapies: Combining different treatment approaches, such as targeted therapies with immunotherapy or chemotherapy, to maximize efficacy.

Pro Tip: Stay informed about clinical trials. Participating in trials gives patients access to the latest advancements in treatment and helps accelerate progress in cancer research. You can find more information at the National Institutes of Health.

The Role of Diagnostics and Imaging

Advanced imaging techniques, like PET/TC-PSMA scans, are critical for early and accurate diagnosis. These scans help locate even small amounts of cancer cells, allowing for earlier intervention. The precision of these diagnostics is crucial in determining the best course of treatment, including whether a patient is a suitable candidate for radioligand therapy. Furthermore, imaging guides treatment, showing how well it is working, allowing for adjustments as needed.

Real-Life Example: A study published in the *Journal of Nuclear Medicine* showed that PSMA-PET/CT significantly improved the detection of prostate cancer recurrence compared to conventional imaging methods.

Personalized Medicine and Biomarkers

The future of prostate cancer treatment is all about personalization. Genomic testing and biomarker analysis help doctors understand the specific genetic makeup of a patient’s cancer. This information informs treatment decisions, helping doctors choose the most effective therapies for individual cases. This moves away from a “one-size-fits-all” approach toward tailored treatment plans.

The Importance of Regional Networks and Collaboration

The success of initiatives like the one in Campania demonstrates the importance of regional collaboration. Having specialized centers, trained professionals, and established pathways of care ensures that patients receive optimal treatment. These networks facilitate knowledge sharing, improve patient access to advanced therapies, and ultimately drive better outcomes.

Frequently Asked Questions (FAQ)

What is radioligand therapy?
A targeted cancer treatment that uses radioactive drugs to destroy cancer cells.
Who is radioligand therapy suitable for?
Patients with advanced prostate cancer, particularly those who have not responded to other treatments.
What are the benefits of radioligand therapy?
Improved survival rates and better quality of life compared to some conventional treatments.
How can I access radioligand therapy?
Consult with your oncologist to determine eligibility and discuss options within your healthcare system.

The progress in prostate cancer treatment is accelerating. With advances in precision medicine, imaging, and collaborative networks, the outlook for patients is brighter than ever. As researchers continue to refine therapies and push the boundaries of innovation, the future holds immense promise for conquering this disease.

Want to learn more? Explore more articles on our site about cancer treatments. Share your thoughts and experiences in the comments below!

0 comments
0 FacebookTwitterPinterestEmail